Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Clearside Biomedical Inc | CLSD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.40 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.650101 - 2.12 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 1.40 | USD |
Clearside Biomedical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
104.61M | 74.72M | - | 8.23M | -32.49M | -0.43 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Clearside Biomedical News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.33 | 1.45 | 1.33 | 1.38 | 120,001 | 0.07 | 5.26% |
1 Month | 1.30 | 1.52 | 1.21 | 1.36 | 205,384 | 0.10 | 7.69% |
3 Months | 1.80 | 2.12 | 1.10 | 1.51 | 322,982 | -0.40 | -22.22% |
6 Months | 1.07 | 2.12 | 0.9243 | 1.44 | 293,360 | 0.33 | 30.84% |
1 Year | 1.17 | 2.12 | 0.650101 | 1.32 | 206,296 | 0.23 | 19.66% |
3 Years | 2.78 | 7.73 | 0.650101 | 3.40 | 560,479 | -1.38 | -49.64% |
5 Years | 1.08 | 7.73 | 0.56 | 2.84 | 582,570 | 0.32 | 29.63% |
Clearside Biomedical Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. |